Sinoway Industrial Co., Ltd.

Sinoway in CPhI Japan (Tokyo) from Apr 18th to Apr 20th, 2018 Sinoway in CPhI Japan (Tokyo) from Apr 18th to Apr 20th, 2018

Cosmetic Peptides

Product Name

CAS No.

Specification

Argireline (Acetyl Hexapeptide-3)

616204-22-9

98% up

Copper peptide(GHK-Cu or AHK-Cu)

49557-75-7

98% up

Matrixyl 3000 (Pal-GHK: Pal-GQPR=2:1)

N/A

95% up

Nonapeptide-1

158563-45-2

95% up

Matrixyl(Palmitoyl Pentapeptide-4)

214047-00-4

98% up

SNAP-8 (Acetyl Octapeptide-8)

868844-74-0

98% up

* Custom Developing /Manufacturing for peptides Derivatives

Prostaglandin Derivatives

Product Name

CAS No.

Specification

Prostaglandin series

key Intermediates

32233-40-2;

70764-05-7 etc.

99% up

Travoprost  Intermediates

54142-64-2;

208111-98-2 etc.

99% up

Bimatoprost Intermediates

41162-19-0;

41639-74-1 etc.

99% up


Latanoprost Intermediates

352276-28-9

41639-83-2 etc

99% up

Cloprostenol Intermediates

54324-79-7

54713-44-9 etc

99% up

*Custom Developing /Manufacturing for Prostaglandin Derivatives
Products under the patent are only for R&D use.

Pharmaceutical Intermediates

Product Name

CAS No.

Specification

( by HPLC)

Rosuvastatin calcium intermediates

147118-40-9;

147118-35-2 etc.

99% up

S. Impurity<0.1%

Pitavastatin calcium intermediates

147511-70-4;

147489-06-3 etc.

99.5%up S. Impurity<0.1%

Febuxostat intermediates

160844-75-7 etc.

99%up

Entecavir intermediate

1354715-15-3etc

99% up

Solifenacin succinateintermediates

118864-75-8 etc.

99%up

Palbociclib intermediates

CAS:1016636-76-2

CAS:571188-59-5

99%up


M-Nitrobenzaldehyde

O-Nitrobenzaldehyde

99-61-6;

552-89-6

99%up

P-Hydroxybenzyl alcohol

623-05-2

99%up

* Custom Developing /Manufacturing for advanced intermediates
Products under the patent are only for R&D use.

APIs

Product Name

Quality(by HPLC)

Developing Status

Azilsartan(Medoxomil)

99%up

DMF,PMDA

Esomeprazole Magnesium dihydrate

99%up

GMP application,

DMF; PMDA

Rabeprazole sodium

CP, JP

GMP, DMF,PMDA

Levetiracetam

99%up

DMF,PMDA,

FDA application

Galantamine hydrobromide



Celecoxib



Mirabegron



Vonoprazan fumarate



Linagliptin/Alogliptin benzoate



Dapagliflozin


Under PV, DMF,PMDA

Lenalidomide

99%up

PMDA, DMF

Rivaroxaban

99.9%up

PMDA, DMF

Apixaban

99.9%up

PMDA, DMF

Products under the patent are only for R&D use.

Plant Extracts
  • Ginkgo Bioloba Extract: USP or EP or
  • Flavonoid glycosides: terpene lactones=36%:10%
  • Epimedium P.E. : Icariin 98%up by HPLC
  • Tribulus terrestris P.E:  80%up by UV
  • Marigold Flower Extract: Lutein 10%up by HPLC  or Lutein 20%up by HPLC
  • Capsanthin: Oil-soluble:100,000CV; Water-soluble 40,000CV
  • Bilberry Extract : Anthocyanidins(UV) 25%up; Anthocyanosides(HPLC) 36%up
  • Stevia Extract: RA 60%up,RA 97% up by HPLC

Cosmetic Raw Materials/Excipient

  • Alpha-arbutin: 99.5%up
  • Guaiazulene: 99.9%up by
  • L-Carnosine: 99%up
  • L-Cysteine Base: AJI92
  • Sodium Hyaluronate: CEP, EP current
  • Natural Creosote: JP16
  • S-Acetyl-L-Glutathione: 98%up
  • S-Adenosyl-L-Methionine Disulfate tosylate: USP36

Hot Item

Product Name

Quality(HPLC)

Rivaroxaban

PMDA ,99.9%up

Etoricoxib


Lacosamide

FDA,DMF,

Silodosin intermediates

CAS:239463-85-5(avoid the patent)

99% up

S. Impurity<0.1%

Febuxostat intermediates

CAS; 161798-01-2(avoid the patent)

99% up by HPLC

S. Impurity<0.1%

Rosuvastatin calcium intermediates CAS:917805-74-4(avoid the patent)

99% up by HPLC,

S. Impurity<0.1%

Lesinurd intermediates

99% up


Products under the patent are only for R&D use.
Related News
  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//